EurekAlert! -
12 Apr 2014 06:00
(University of Texas Health Science Center at San Antonio) Twelve weeks of an investigational oral therapy cured hepatitis C infection in more than 90 percent of patients with liver cirrhosis and was well tolerated by these patients, according to an international study that included researchers from UT Medicine San Antonio and the Texas Liver Institute.
Share this Article